Kevin Lorenz - Jan 1, 2024 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role
Director
Signature
/s/ Samuel Berry, Attorney-in-Fact
Stock symbol
FBIO
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
4
Date filed
1/3/2024, 04:54 PM
Previous filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBIO COMMON STOCK, PAR VALUE $0.001 Award $0 +3.33K +15.89% $0.00 24.3K Jan 1, 2024 Direct F1, F2
holding FBIO COMMON STOCK, PAR VALUE $0.001 666 Jan 1, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
F2 One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service.